TARO Company Profile
✉ Email this page to a colleague
What is the competitive landscape for TARO, and what generic alternatives to TARO drugs are available?
TARO has two hundred and fifty-three approved drugs.
There are eight US patents protecting TARO drugs. There are four tentative approvals on TARO drugs.
There are thirty-one patent family members on TARO drugs in twelve countries and one hundred and seventy-three supplementary protection certificates in fourteen countries.
Summary for TARO
| International Patents: | 31 |
| US Patents: | 8 |
| Tradenames: | 133 |
| Ingredients: | 116 |
| NDAs: | 253 |
| Patent Litigation for TARO: | See patent lawsuits for TARO |
| PTAB Cases with TARO as petitioner: | See PTAB cases with TARO as petitioner |
Drugs and US Patents for TARO
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Taro | FLUCONAZOLE | fluconazole | TABLET;ORAL | 076507-002 | Jul 29, 2004 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Taro | MUPIROCIN | mupirocin calcium | CREAM;TOPICAL | 207116-001 | Apr 27, 2020 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Taro | FLUPHENAZINE HYDROCHLORIDE | fluphenazine hydrochloride | TABLET;ORAL | 215674-002 | Apr 14, 2022 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Taro | FLUOCINOLONE ACETONIDE | fluocinolone acetonide | CREAM;TOPICAL | 087104-001 | Apr 27, 1982 | AT | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Taro | AMINOCAPROIC ACID | aminocaproic acid | SOLUTION;ORAL | 214458-001 | Mar 24, 2023 | AA | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Taro | NYSTATIN AND TRIAMCINOLONE ACETONIDE | nystatin; triamcinolone acetonide | CREAM;TOPICAL | 062364-001 | Dec 22, 1987 | AT | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for TARO
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Taro | FLO-PRED | prednisolone acetate | SUSPENSION;ORAL | 022067-002 | Jan 17, 2008 | 6,656,482 | ⤷ Try a Trial |
| Taro | FLO-PRED | prednisolone acetate | SUSPENSION;ORAL | 022067-001 | Jan 17, 2008 | 5,881,926 | ⤷ Try a Trial |
| Taro | TOPICORT | desoximetasone | SPRAY;TOPICAL | 204141-001 | Apr 11, 2013 | 5,990,100 | ⤷ Try a Trial |
| Taro | PLIAGLIS | lidocaine; tetracaine | CREAM;TOPICAL | 021717-001 | Jun 29, 2006 | 5,919,479 | ⤷ Try a Trial |
| Taro | FLO-PRED | prednisolone acetate | SUSPENSION;ORAL | 022067-002 | Jan 17, 2008 | 6,071,523 | ⤷ Try a Trial |
| Taro | FLO-PRED | prednisolone acetate | SUSPENSION;ORAL | 022067-002 | Jan 17, 2008 | 5,881,926 | ⤷ Try a Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for TARO drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Topical Lotion | 0.5% | ➤ Subscribe | 2011-03-16 |
| ➤ Subscribe | Topical Spray | 0.25% | ➤ Subscribe | 2013-12-18 |
International Patents for TARO Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Japan | 2009503097 | ⤷ Try a Trial |
| South Africa | 200800926 | ⤷ Try a Trial |
| China | 103087095 | ⤷ Try a Trial |
| Canada | 2609579 | ⤷ Try a Trial |
| Australia | 2011205730 | ⤷ Try a Trial |
| Australia | 2006278620 | ⤷ Try a Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for TARO Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1667986 | 92172 | Luxembourg | ⤷ Try a Trial | PRODUCT NAME: SOLVAT ACETONIQUE DU CABAZITAXEL, OU DESIGNE SOLVAT ACETONIQUE DU DIMETHOXY DOCETAXEL OU SOLVAT ACETONIQUE DU (2R,3S)-3-TERT-BUTOXYCARBONYLAMINO-2-HYDROXY-3-PHENYLPROPIONATE DE 4-ACETOXY-2A-BENZOYLOXY-5BETA,20-EPOXY-1-HYDROXY-7BETA,10A-DIMETHOXY-9-OXO-TAX-11-ENE-13A-YLE(ACETONATE DU CABAZITAXEL) |
| 1304992 | C300617 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: COMBINATIE VAN CLINDAMYCINE, DESGEWENST IN DE VORM VAN CLINDAMYCINEFOSFAAT EN TRETINOINE; NAT. REGISTRATION NO/DATE: RVG 109745 20130626; FIRST REGISTRATION: PA1332/043/001 20130322 |
| 0480717 | SPC/GB98/025 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: MONTELUKAST, OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PREFERABLY MONTELUKAST SODIUM; REGISTERED: FI 12766 19970825; FI 12767 19970825; UK 00025/0357 19980115; UK 00025/0358 19980115 |
| 1305329 | 08C0014 | France | ⤷ Try a Trial | PRODUCT NAME: FLUTICASONE FUROATE; REGISTRATION NO/DATE: EU/1/07/434/001 20080111 |
| 1429780 | SPC/GB12/058 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: A COMBINATION OF CIPROFLOXACIN AND DEXAMETHASONE, PREFERABLY CIPROFLOXACIN HYDROCHLORIDE AND DEXAMETHASONE; REGISTERED: DK DE/11/3337/001/DC 20120808; UK PL000649/0381-0001 20121003 |
| 1856135 | CA 2020 00018 | Denmark | ⤷ Try a Trial | PRODUCT NAME: FOSTAMATINIB OR A PHARMACEUTICALLY ACCEPTABLE SALT OF FOSTAMATINIB, OR A HYDRATE, SOLVATE OR N-OXIDE OF FOSTAMATINIB OR THE PHARMACEUTICALLY ACCEPTABLE SALT OF FOSTAMATINIB, ESPECIALLY FOSTAMATINIB DISODIUM, OPTIONALLY IN FORM OF A HYDRATE; REG. NO/DATE: EU/1/19/1405 20200113 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
